In one study, intratumoral LAG3+ TIL were detected in 11% of tumors and significantly associated with more aggressive clinicopathological parameters, including: Young age, large tumor size, high proliferation, which also typically characterize the more aggressive HER2-enriched and basal-like BC subtypes [70]. Here, ERBB2 is linked to breast cancer.